Menu

• Ask a Health Expert about HEPATIC ATROPHY
• Post Your Side Effect related to HEPATIC ATROPHY
• HEPATIC ATROPHY and FDA Warnings
• HEPATIC ATROPHY in Patients Wiki
• Report HEPATIC ATROPHY in Drug Side Effect Survey

HEPATIC ATROPHY side effect

What is HEPATIC ATROPHY ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Leuprolide Side Effects Report #5542071-5
Health Professional from JAPAN reported LEUPROLIDE ACETATE problem on Nov 26, 2007. Female patient, 49 years of age, was diagnosed with breast cancer and was treated with LEUPROLIDE ACETATE. After drug was administered, patient experienced the following problems/side effects: hepatic atrophy, metastases to liver, . LEUPROLIDE ACETATE dosage: 11.25 MG (11.25 MG,1 IN 12 WK). During the same period patient was treated with TAXOTERE, NAVELBINE, GLYCYRON, LASIX, FEMARA. Patient died.

Herceptin Side Effects Report #5469400-5
HERCEPTIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 13, 2007. Female patient, 44 years of age, was diagnosed with breast cancer and was treated with HERCEPTIN. After drug was administered, patient experienced the following problems/side effects: hepatic atrophy, hepatic failure, . HERCEPTIN dosage: 2 MG/KG, 1/WEEK. During the same period patient was treated with PACLITAXEL, TAMOXIFEN CITRATE. Patient died on 07/06/2005.

Leuprolide Side Effects Report #5572323-4
Consumer or non-health professional from JAPAN reported LEUPROLIDE ACETATE problem on Dec 17, 2007. Female patient, 49 years of age, was diagnosed with breast cancer and was treated with LEUPROLIDE ACETATE. After drug was administered, patient experienced the following problems/side effects: breast cancer female, hepatic atrophy, malignant neoplasm progression, metastases to liver, . LEUPROLIDE ACETATE dosage: 11.25 MG (11.25 MG, 1 IN 12 WK), SUBCUTANEOUS. During the same period patient was treated with TAXOTERE, NAVELBINE, GLYCYRON, LASIX, FEMARA. Patient died.

Candesartan Side Effects Report #5426135-2
CANDESARTAN CILEXETIL problem was reported by a Physician from JAPAN on Aug 21, 2007. Male patient, 56 years of age, was diagnosed with hypertension and was treated with CANDESARTAN CILEXETIL. After drug was administered, patient experienced the following problems/side effects: acute hepatic failure, hepatic atrophy, hepatitis fulminant, respiratory rate increased, . CANDESARTAN CILEXETIL dosage: unknown. During the same period patient was treated with WARFARIN, FAMOTIDINE, RYTHMODAN R, PERSANTIN. Patient was hospitalized. Patient recovered.


Pepcid Side Effects Report #5440821-X
Physician from JAPAN reported PEPCID RPD problem on Aug 29, 2007. Male patient, 56 years of age, was treated with PEPCID RPD. After drug was administered, patient experienced the following problems/side effects: continuous haemodiafiltration, hepatic atrophy, hepatic encephalopathy, hepatitis fulminant, liver transplant, no therapeutic response, . PEPCID RPD dosage: unknown. During the same period patient was treated with PERSANTINE, RYTHMODAN, CANDESARTAN CILEXETIL, WARFARIN. Patient was hospitalized. Patient recovered.

Clofarabine Side Effects Report #5796289-7
CLOFARABINE problem was reported by a Physician from UNITED STATES on June 18, 2008. Female patient, 68 years of age, weighting 143.7 lb, was diagnosed with stem cell transplant and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: ascites, hepatic atrophy, pleural effusion, portal vein flow decreased, stem cell transplant, weight increased, . CLOFARABINE dosage: 30 MG/M2, QD, INTRAVENOUS. During the same period patient was treated with BUSULFAN, URSODIOL, CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Clofarabine Side Effects Report #5756938-6
Health Professional from UNITED STATES reported CLOFARABINE problem on May 22, 2008. Female patient was diagnosed with stem cell transplant and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: ascites, hepatic atrophy, portal vein flow decreased, weight increased, . CLOFARABINE dosage: 30 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with BUSULFAN. Patient was hospitalized. Patient recovered.

Citalopram Side Effects Report #5692874-1
CITALOPRAM HYDROBROMIDE problem was reported by a Health Professional from GERMANY on Mar 19, 2008. Female patient, 56 years of age, was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: asthenia, hepatic atrophy, hepatic necrosis, hepatitis acute, hepatomegaly, weight decreased, . CITALOPRAM HYDROBROMIDE dosage: 20 MG QD PO. Patient was hospitalized. Patient recovered.